𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Magnetic resonance studies of intramuscular interferon β–1a for relapsing multiple sclerosis

✍ Scribed by Dr Jack H. Simon; Lawrence D. Jacobs; Marilyn Campion; Karl Wende; Nancy Simonian; Diane L. Cookfair; Richard A. Rudick; Robert M. Herndon; John R. Richert; Andres M. Salazar; John J. Alam; Jill S. Fischer; Donald E. Goodkin; Carl V. Granger; Michelle Lajaunie; Anna L. Martens-Davidson; Maryjoel Meyer; Jeanelle Sheeder; Kim Choi; Ann L. Scherzinger; David M. Bartoszak; Dennis N. Bourdette; Jonathan Braiman; Carol M. Brownscheidle; Michael E. Coats; Stanley L. Cohan; David S. Dougherty; Revere P. Kinkel; Michele K. Mass; Fredrick E. Munschauer III; Roger L. Priore Scd; Patrick M. Pullicino; Barbara J. Scherokman; Bianca Weinstock-Guttman; Ruth H. Whitham

Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
862 KB
Volume
43
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Magnetic resonance imaging results of th
Magnetic resonance imaging results of the PRISMS trial: A randomized, double-blind, placebo-controlled study of interferon-β1a in relapsing-remitting multiple sclerosis
✍ David K. B. Li; Donald W. Paty 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB 👁 2 views

The PRISMS (Prevention of Relapses and Disability by Interferon-␤1a Subcutaneously in Multiple Sclerosis) trial was a doubleblind, randomized, multicenter, phase III, placebo-controlled study of interferon-␤1a in 560 patients from 22 centers in 9 countries with clinically definite or laboratory-supp

Identify of interferon-β1a product in mu
Identify of interferon-β1a product in multiple sclerosis study
✍ Wieland W. Wolf 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 1 views

We extend sincere congratulations to Dr Jacobs and colleagues for the successful conclusion of their study of recombinant interferon p l a (rIFN-pla) in patients with multiple sclerosis (MS). The impressive results showed that 6 million international units of rIFN-Pla applied once weekly via the int

Real-life impact of early interferonβ th
Real-life impact of early interferonβ therapy in relapsing multiple sclerosis
✍ M. Trojano; F. Pellegrini; D. Paolicelli; A. Fuiani; G.B. Zimatore; C. Tortorell 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB 👁 1 views

## Abstract ## Objective Recent findings support greater efficacy of early vs. delayed interferon beta (IFNβ) treatment in patients with a first clinical event suggestive of multiple sclerosis (MS). We aimed to evaluate the effectiveness of early IFNβ treatment in definite relapsing‐remitting MS (